High Efficacy of Pingxiao Capsule Combines with Docetaxel and Cisplatin Induction Chemotherapy on Oral Squamous Cell Carcinoma in Mice

Author:

Zhao Caijun1,Han Xinguang2,Bao Chongyun3

Affiliation:

1. Department of Stomatology, Clinical Medical College of Tianjin Medical University, Tianjin 300270, China

2. Department of Oral Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China

3. Department of Oral Surgery, West China Hospital of Stomatology Sichuan University, Chengdu 610041, Sichuan, China

Abstract

This study explored the effect of docetaxel and cisplatin on oral squamous cell carcinoma and its modulation by the traditional Chinese medicine Pingxiao capsule. To this end, CAL27 cells were injected subcutaneously into the right axilla of the nude mice to produce solid tumors. The tumor-bearing mice were treated with docetaxel, cisplatin, Pingxiao capsule, cisplatin + docetaxel, cisplatin + Pingxiao capsule, docetaxel + Pingxiao capsule, or cisplatin + docetaxel + Pingxiao capsule, and the treatment outcomes were compared with control. The outcome measures included tumor size, mouse body weight, and tumor histopathology. The results revealed that a single dose of docetaxel, cisplatin, and Pingxiao capsules was effective in suppressing mice tumor volume and body weight, enhancing apoptotic index, and reducing proliferation index. However, the use of a combination of drugs had better effects than the use of any single drug. To conclude, the combination of docetaxel, cisplatin, and Pingxiao capsule has high efficacy in repressing tumor growth by repressing tumor cell proliferation and facilitating tumor cell apoptosis.

Publisher

New Century Health Publishers LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3